CEBINA identifies Azelastine as the possible approach against COVID-19.

Global Banking News-July 10, 2020-CEBINA identifies Azelastine as the possible approach against COVID-19

(C)2020 ENPublishing - http://www.enpublishing.co.uk

Austrian biotechnology company CEBINA GmbH on Thursday announced that the already approved and the most commonly used nasal spray Azelastine has demonstrated action against SARS-CoV-2 infection in in vitro tests.

In partnership with University of Vienna, Austria, CEBINA used a computational approach, integrated several software tools and a new analysis of biological pathways to identify possible drugs to combat COVID-19 as well as conducted in vitro viral infection test in SARS-CoV-2 at the BSL-4 laboratory at the Szentagothai Research Center...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT